These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27315562)

  • 61. Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls.
    Roach JL; Turenne MN; Hirth RA; Wheeler JR; Sleeman KS; Messana JM
    Am J Kidney Dis; 2010 Nov; 56(5):928-36. PubMed ID: 20888100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: rationale and methods for an initiative to monitor the new US bundled dialysis payment system.
    Robinson B; Fuller D; Zinsser D; Albert J; Gillespie B; Tentori F; Turenne M; Port F; Pisoni R
    Am J Kidney Dis; 2011 Jun; 57(6):822-31. PubMed ID: 21530036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. What can we expect down the road?
    Sullivan J
    Nephrol News Issues; 2011 Apr; 25(4):28-9. PubMed ID: 21542511
    [No Abstract]   [Full Text] [Related]  

  • 64. Who should be paying for vitamin D analogues--Medicare or the patients?
    Grotegut J
    Nephrol Nurs J; 2006; 33(3):345-6. PubMed ID: 16912996
    [No Abstract]   [Full Text] [Related]  

  • 65. Altering the dialysis prescription.
    Neumann ME
    Nephrol News Issues; 1999 Nov; 13(11):18-9. PubMed ID: 10865620
    [No Abstract]   [Full Text] [Related]  

  • 66. Medicare ESRD prospective payment system: weighing the evidence.
    Himmelfarb J; Chertow GM
    J Am Soc Nephrol; 2005 May; 16(5):1164-5. PubMed ID: 15829705
    [No Abstract]   [Full Text] [Related]  

  • 67. New ESRD clinical performance measures and data collection system: progress and pitfalls.
    Wish JB
    Nephrol News Issues; 2008 Jul; 22(8):12-3. PubMed ID: 18711877
    [No Abstract]   [Full Text] [Related]  

  • 68. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016.
    Hoffman A; Sloan CE; Maciejewski ML; Wang V
    JAMA; 2020 Apr; 323(13):1314-1316. PubMed ID: 32259222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-quality trade-offs in dialysis care: a national survey of dialysis facility administrators.
    Powe NR; Thamer M; Hwang W; Fink NE; Bass EB; Sadler JH; Levin NW
    Am J Kidney Dis; 2002 Jan; 39(1):116-26. PubMed ID: 11774110
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The impact of the bundle on lab services.
    Burney M
    Nephrol News Issues; 2011 Jul; 25(8):14-5. PubMed ID: 21877618
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Excluded from universal coverage: ESRD patients not covered by Medicare.
    Thamer M; Ray NF; Richard C; Greer JW; Pearson BC; Cotter DJ
    Health Care Financ Rev; 1995; 17(2):123-46. PubMed ID: 10157372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
    Hidai H
    Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medicare Program; Conditions for Coverage for End-Stage Renal Disease Facilities--Third Party Payment. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Dec; 81(240):90211-28. PubMed ID: 28001019
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluating the Evidence behind Policy Mandates in US Dialysis Care.
    Erickson KF; Winkelmayer WC
    J Am Soc Nephrol; 2018 Dec; 29(12):2777-2779. PubMed ID: 30389727
    [No Abstract]   [Full Text] [Related]  

  • 76. Trends in prevalence of patient case-mix adjusters used in the Medicare dialysis payment system.
    Hollenbeak CS; Rubin RJ; Tzivelekis S; Stephens JM
    Nephrol News Issues; 2015 Jun; 29(6):24-7, 31-4. PubMed ID: 26237942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regional Variations in the Interpretation of the End-Stage Renal Disease Thirty-Month Coordination Period: Potential Implications for Patient Care.
    Harford R; Clark MJ; Yan G; Flaque J; Colon J; Torre F; Rodriguez Y; Norris KC
    J Health Care Poor Underserved; 2017; 28(4):1245-1253. PubMed ID: 29176092
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Health care policies/economics of the geriatric renal population.
    Eggers PW
    Am J Kidney Dis; 1990 Oct; 16(4):384-91. PubMed ID: 2121023
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Can we revitalize the ESRD program?
    McFeeley T
    Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164
    [No Abstract]   [Full Text] [Related]  

  • 80. Patient selection in the Medicare End-Stage Renal Disease Program.
    de Lissovoy G
    Med Care; 1988 Oct; 26(10):959-70. PubMed ID: 3139942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.